Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P3.03-23 a Propensity Score Matching Cohort Study on Prognosis of the Diversity of MUC1 Expression in Patients With Lung Adenocarcinoma

Journal of Thoracic Oncology

English

OA08.07 in Silico Discovery of Unannotated miRNAs in Malignant Pleural Mesothelioma Reveals Novel Tissue-Of-Origin Markers

Journal of Thoracic Oncology

English

PC08.07 Debate #3: Brain Metastases With a Driver Mutation Should Be Treated With Systemic Therapy First (PRO)

Journal of Thoracic Oncology

English

MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC

Journal of Thoracic Oncology

English

MA07.10 Utilizing a Personalized Navigation Program to Identify Barriers and Increase Clinical Trial Participation Among Lung Cancer Patients

Journal of Thoracic Oncology

English

P2.04-30 PD-1/PD-L1 Inhibition Might Be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma

Journal of Thoracic Oncology

English

P2.03-17 EGFR T790M Mutation May Not Be Generated Through Selection by EGFR-TKI From Randomly Occurring Mutations in Vitro Using ENU

Journal of Thoracic Oncology

English

P1.01-90 a Pilot Trial Assessing Apatinib Combined With Docetaxel (DTX) as Second-Line Chemotherapy for EGFR Negative Advanced NSCLC)

Journal of Thoracic Oncology

English

High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology

Journal of Thoracic Oncology

English

An Original Case of an Association of Eosinophilic Fasciitis With Cholangitis Induced by Nivolumab

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P3.03-23 a Propensity Score Matching Cohort Study on Prognosis of the Diversity of MUC1 Expression in Patients With Lung Adenocarcinoma

OA08.07 in Silico Discovery of Unannotated miRNAs in Malignant Pleural Mesothelioma Reveals Novel Tissue-Of-Origin Markers

PC08.07 Debate #3: Brain Metastases With a Driver Mutation Should Be Treated With Systemic Therapy First (PRO)

MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC

MA07.10 Utilizing a Personalized Navigation Program to Identify Barriers and Increase Clinical Trial Participation Among Lung Cancer Patients

P2.04-30 PD-1/PD-L1 Inhibition Might Be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma

P2.03-17 EGFR T790M Mutation May Not Be Generated Through Selection by EGFR-TKI From Randomly Occurring Mutations in Vitro Using ENU

P1.01-90 a Pilot Trial Assessing Apatinib Combined With Docetaxel (DTX) as Second-Line Chemotherapy for EGFR Negative Advanced NSCLC)

High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology

An Original Case of an Association of Eosinophilic Fasciitis With Cholangitis Induced by Nivolumab